Pharmafile Logo
Pharmafocus logo
Advanced Search

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026
Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy

Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …

News

PSI appoints David Allen as Country Manager for Canada

January 22, 2026
Country Manager for Canada, PSI

PSI, a contract research organisation (CRO) with a focus on clinical trial delivery, has announced the appointment of David Allen …

Appointment

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026
Qureight, chief medical officer

Qureight has announced the appointment of Dr Steven Bishop as its new Chief Medical Officer (CMO). Bishop previously held the …

Appointment

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026
Research and Development Iktos, Oncology, Pierre Fabre Laboratories

Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …

News

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026
Qureight, chief operating officer

Qureight has announced the appointment of Rebecca Simmons as Chief Operating Officer (COO). Simmons brings more than two decades of …

Appointment

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026
Research and Development European Medicines Agency, Rare Diseases

The European Medicines Agency (EMA) has announced data from 2025 showing that over the course of the year it recommended …

News

Spike in searches relating to spinal muscular atrophy following Jesy Nelson disclosure

January 19, 2026
Medical Education Neurology, spinal muscular atrophy

New research from the Centre for Surgery has shown a significant rise in Google searches relating to spinal muscular atrophy …

News

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

January 19, 2026
Research and Development Biogen, Neurology, Spinraza, spinal muscular atrophy

Biogen’s Spinraza (nusinersen) has received approval from the European Commission (EC) as a new high-dose regimen for the treatment of …

News

Alto Neuroscience announces new patent for depression treatment

January 15, 2026
Sales and Marketing Alto Neuroscience, Psychiatry, depression

Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …

News

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026
Sales and Marketing Arkin Capital, biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …

News

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026
Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer

Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …

News

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026
Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …

News

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026
Research and Development Blue Earth Therapeutics, Oncology, prostate cancer

Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first UK patient has received its …

News

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026
Research and Development Endocrinology, Medicus Pharma, Teverelix

Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …

News

PSI announces new Osaka office as part of Japanese expansion

January 12, 2026
Sales and Marketing Osaka, PSI

PSI, a global contract research organisation (CRO), has announced the opening of a new office in Osaka as part of …

News

Teva’s Ajovy significantly reduces migraine in children and adolescents

January 12, 2026
Research and Development Neurology, Teva, ajovy, migraine

Teva’s Ajovy (fremanezumab) has demonstrated significant reduction in monthly migraine and headache days in children and adolescents with episodic migraine …

News

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026
Research and Development Gates Foundation, Just – Evotec Biologics

Evotec has announced that its subsidiary, Just – Evotec Biologics, has received a Gates Foundation grant with the goal of …

News

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026
Research and Development FDA, Gastrointestinal tract, Johnson & Johnson

Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De Novo classification from the US …

News

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026
Research and Development Psychiatry, ea pharma, schizophrenia

EA Pharma, a subsidiary of Eisai, has announced the initiation of a phase 3 clinical trial of evenamide, a schizophrenia …

News

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026
Chief Business Officer, Eleva

Eleva, a biopharmaceutical company specialising in formerly inaccessible biologics, has announced the appointment of Dr Erich Rajkovic as Chief Business …

Appointment

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026
Manufacturing and Production FDA, MedPharm

MedPharm has announced that the US Food and Drug Administration (FDA) has completed a successful inspection of its topical drug …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026